Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.
MEK/RTK通路共抑制对KRAS突变型非小细胞肺癌具有很高的治疗效果
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02382-w
Lu Jun, Hu Minjuan, Zhao Yikai, Chu Tianqing, Zhang Wei, Zhou Yijia, Cai Xinlei, Wu Jun, Hu Liang, Shi Chunlei, Xiong Liwen, Gu Aiqin, Wang Huimin, Zhang Yanwei, Lou Yuqing, Zhong Runbo, Gao Zhiqiang, Liu Hongyu, Zhou Chao, Wu Yingli, Zhu Liang, Zhong Hua, Ji Hongbin, Han Baohui
